• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌衍生生长因子在促进肝细胞癌中新生脂肪生成和肿瘤发生中的作用。

Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.

机构信息

Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, China.

Shanghai University of Medicine & Health Sciences, China.

出版信息

Mol Oncol. 2018 Sep;12(9):1480-1497. doi: 10.1002/1878-0261.12357. Epub 2018 Aug 7.

DOI:10.1002/1878-0261.12357
PMID:30004626
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6120245/
Abstract

Although identified as a growth factor, the mechanism by which hepatoma-derived growth factor (HDGF) promotes cancer development remains unclear. We found that nuclear but not cytoplasmic HDGF is closely associated with prognosis of hepatocellular carcinoma (HCC). RNA-sequencing analysis further demonstrated that the nuclear role of HDGF involved regulation of transcription of lipid metabolism genes. HDGF-induced expression of lipogenic genes was mainly associated with activation of sterol regulatory element binding protein (SREBP) transcription factor. Coexpression of SREBP-1 and nuclear HDGF predicts poor prognosis for HCC. In addition, by changing the first amino acid of the PWWP domain from proline to alanine, the type of PWWP domain changed from P- to A-type, resulting in inability to induce SREBP-1-mediated gene transcription. The type of PWWP domain affects the recruitment of the C-terminal binding protein-1 transcriptional repressor on the promoter of the lipogenic gene. Our data indicate that HDGF acts as a coactivator of SREBP1-mediated transcription of lipogenic genes. The PWWP domain is crucial for HDGF to promote lipogenesis. Moreover, transcriptional regulation of nuclear HDGF plays important roles in the development of HCC.

摘要

虽然已被鉴定为生长因子,但肝癌衍生生长因子(HDGF)促进癌症发展的机制仍不清楚。我们发现核内而非细胞质中的 HDGF 与肝细胞癌(HCC)的预后密切相关。RNA 测序分析进一步表明,HDGF 的核作用涉及脂质代谢基因转录的调节。HDGF 诱导的生脂基因表达主要与固醇调节元件结合蛋白(SREBP)转录因子的激活有关。SREBP-1 和核内 HDGF 的共表达预测 HCC 的预后不良。此外,通过将 PWWP 结构域的第一个氨基酸从脯氨酸变为丙氨酸,PWWP 结构域的类型从 P 型变为 A 型,导致无法诱导 SREBP-1 介导的基因转录。PWWP 结构域的类型影响 C 端结合蛋白-1 转录抑制剂在生脂基因启动子上的募集。我们的数据表明,HDGF 作为 SREBP1 介导的生脂基因转录的共激活因子发挥作用。PWWP 结构域对于 HDGF 促进生脂作用至关重要。此外,核内 HDGF 的转录调控在 HCC 的发展中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/22eb6f65ea84/MOL2-12-1480-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/a4b19d85d828/MOL2-12-1480-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/b61f724abd34/MOL2-12-1480-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/0ad3ac5414b3/MOL2-12-1480-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/a57443a6e9b8/MOL2-12-1480-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/2527ffee2cdb/MOL2-12-1480-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/ceff35a05aa2/MOL2-12-1480-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/d5359e8816d7/MOL2-12-1480-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/22eb6f65ea84/MOL2-12-1480-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/a4b19d85d828/MOL2-12-1480-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/b61f724abd34/MOL2-12-1480-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/0ad3ac5414b3/MOL2-12-1480-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/a57443a6e9b8/MOL2-12-1480-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/2527ffee2cdb/MOL2-12-1480-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/ceff35a05aa2/MOL2-12-1480-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/d5359e8816d7/MOL2-12-1480-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ad/6120245/22eb6f65ea84/MOL2-12-1480-g008.jpg

相似文献

1
Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.肝癌衍生生长因子在促进肝细胞癌中新生脂肪生成和肿瘤发生中的作用。
Mol Oncol. 2018 Sep;12(9):1480-1497. doi: 10.1002/1878-0261.12357. Epub 2018 Aug 7.
2
Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.肝癌衍生生长因子/核仁素轴作为肝癌发生中的一种新型致癌途径。
Oncotarget. 2015 Jun 30;6(18):16253-70. doi: 10.18632/oncotarget.3608.
3
Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma.肝癌衍生生长因子:其可能参与肝细胞癌的进展
Int J Mol Sci. 2015 Jun 19;16(6):14086-97. doi: 10.3390/ijms160614086.
4
Pyruvate kinase M2 interacts with nuclear sterol regulatory element-binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma.丙酮酸激酶 M2 与核固醇调节元件结合蛋白 1a 相互作用,从而激活肝癌中的脂肪生成和细胞增殖。
J Biol Chem. 2018 Apr 27;293(17):6623-6634. doi: 10.1074/jbc.RA117.000100. Epub 2018 Mar 7.
5
ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p.ZHX2 通过 miR-24-3p 抑制肝癌细胞中 SREBP1c 介导的从头脂肪生成。
J Pathol. 2020 Dec;252(4):358-370. doi: 10.1002/path.5530. Epub 2020 Sep 14.
6
Expression of hepatoma-derived growth factor in hepatocellular carcinoma.肝癌衍生生长因子在肝细胞癌中的表达。
Cancer. 2003 Oct 1;98(7):1444-56. doi: 10.1002/cncr.11653.
7
The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.糖异生酶 PCK1 将 INSIG1/2 磷酸化以进行脂肪生成。
Nature. 2020 Apr;580(7804):530-535. doi: 10.1038/s41586-020-2183-2. Epub 2020 Apr 8.
8
Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.肝癌衍生生长因子促进肝癌细胞的生长和转移。
Cell Biochem Funct. 2016 Jun;34(4):274-85. doi: 10.1002/cbf.3189.
9
Hepatoma-derived growth factor represses SET and MYND domain containing 1 gene expression through interaction with C-terminal binding protein.肝癌衍生生长因子通过与C端结合蛋白相互作用抑制含SET和MYND结构域蛋白1基因的表达。
J Mol Biol. 2009 Mar 6;386(4):938-50. doi: 10.1016/j.jmb.2008.12.080. Epub 2009 Jan 8.
10
Hepatocellular Carcinoma-Associated Protein TD26 Interacts and Enhances Sterol Regulatory Element-Binding Protein 1 Activity to Promote Tumor Cell Proliferation and Growth.肝癌相关蛋白 TD26 相互作用并增强固醇调节元件结合蛋白 1 的活性,促进肿瘤细胞增殖和生长。
Hepatology. 2018 Nov;68(5):1833-1850. doi: 10.1002/hep.30030. Epub 2018 Sep 19.

引用本文的文献

1
Unlocking the lipid code: SREBPs as key drivers in gastrointestinal tumour metabolism.破解脂质密码:固醇调节元件结合蛋白作为胃肠道肿瘤代谢的关键驱动因素
Lipids Health Dis. 2025 May 24;24(1):190. doi: 10.1186/s12944-025-02612-8.
2
HRP2 regulating MICU1-mediated Ca overload to dictate chemoresistance of multiple myeloma.HRP2通过调节MICU1介导的钙超载来决定多发性骨髓瘤的化疗耐药性。
Neoplasia. 2025 Apr;62:101150. doi: 10.1016/j.neo.2025.101150. Epub 2025 Mar 8.
3
TENT5A mediates the cancer-inhibiting effects of EGR1 by suppressing the protein stability of RPL35 in hepatocellular carcinoma.

本文引用的文献

1
Domain swapping and SMYD1 interactions with the PWWP domain of human hepatoma-derived growth factor.结构域交换及 SMYD1 与人类肝癌衍生生长因子 PWWP 结构域的相互作用。
Sci Rep. 2018 Jan 10;8(1):287. doi: 10.1038/s41598-017-18510-8.
2
Protein-protein and protein-chromatin interactions of LEDGF/p75 as novel drug targets.LEDGF/p75的蛋白质-蛋白质和蛋白质-染色质相互作用作为新型药物靶点。
Drug Discov Today Technol. 2017 Jun;24:25-31. doi: 10.1016/j.ddtec.2017.11.002. Epub 2017 Nov 23.
3
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.
TENT5A通过抑制肝细胞癌中RPL35的蛋白质稳定性来介导EGR1的癌症抑制作用。
Cell Oncol (Dordr). 2024 Dec;47(6):2247-2264. doi: 10.1007/s13402-024-01014-9. Epub 2024 Nov 21.
4
The roles and mechanisms of SREBP1 in cancer development and drug response.SREBP1在癌症发展和药物反应中的作用及机制。
Genes Dis. 2023 Jun 22;11(4):100987. doi: 10.1016/j.gendis.2023.04.022. eCollection 2024 Jul.
5
SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies.肝脏疾病中SREBP对脂质代谢的调控及治疗策略
Biomedicines. 2023 Dec 12;11(12):3280. doi: 10.3390/biomedicines11123280.
6
Regulation and targeting of SREBP-1 in hepatocellular carcinoma.SREBP-1 在肝细胞癌中的调控和靶向治疗。
Cancer Metastasis Rev. 2024 Jun;43(2):673-708. doi: 10.1007/s10555-023-10156-5. Epub 2023 Dec 1.
7
Determination of the Possible Target Genes of Hepatoma-derived Growth Factor in Hepatoma Cells.测定肝癌细胞中肝癌衍生生长因子的可能靶基因。
In Vivo. 2023 Sep-Oct;37(5):1975-1979. doi: 10.21873/invivo.13294.
8
Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer.靶向SREBP-1介导的脂肪生成作为癌症的潜在治疗策略
Front Oncol. 2022 Jul 14;12:952371. doi: 10.3389/fonc.2022.952371. eCollection 2022.
9
NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.核仁磷酸蛋白1样蛋白1(NAP1L1)与肝癌衍生生长因子相互作用,募集c-Jun诱导乳腺癌生长。
Cancer Cell Int. 2021 Nov 13;21(1):605. doi: 10.1186/s12935-021-02301-3.
10
NAP1L1 Functions as a Tumor Promoter Recruiting Hepatoma-Derived Growth Factor/c-Jun Signal in Hepatocellular Carcinoma.NAP1L1作为肿瘤促进因子在肝细胞癌中募集肝癌衍生生长因子/c-Jun信号。
Front Cell Dev Biol. 2021 Jul 23;9:659680. doi: 10.3389/fcell.2021.659680. eCollection 2021.
2015 年全球疾病负担研究:1990 年至 2015 年全球、区域和国家一级原发性肝癌及相关病因负担。
JAMA Oncol. 2017 Dec 1;3(12):1683-1691. doi: 10.1001/jamaoncol.2017.3055.
4
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology.SREBP 调控的脂质代谢:趋同的生理学-不同的病理生理学。
Nat Rev Endocrinol. 2017 Dec;13(12):710-730. doi: 10.1038/nrendo.2017.91. Epub 2017 Aug 29.
5
A pathology atlas of the human cancer transcriptome.人类癌症转录组病理学图谱。
Science. 2017 Aug 18;357(6352). doi: 10.1126/science.aan2507.
6
PWWP domains and their modes of sensing DNA and histone methylated lysines.PWWP结构域及其识别DNA和组蛋白甲基化赖氨酸的模式。
Biophys Rev. 2016 Mar;8(1):63-74. doi: 10.1007/s12551-015-0190-6. Epub 2016 Jan 14.
7
De novo Assembly and Characterization of the Fruit Transcriptome of Idesia polycarpa Reveals Candidate Genes for Lipid Biosynthesis.山桐子果实转录组的从头组装与特征分析揭示了脂质生物合成的候选基因。
Front Plant Sci. 2016 Jun 7;7:801. doi: 10.3389/fpls.2016.00801. eCollection 2016.
8
International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007.1978 - 2007年肝癌发病率的国际趋势,总体及按组织学亚型划分的趋势
Int J Cancer. 2016 Oct 1;139(7):1534-45. doi: 10.1002/ijc.30211. Epub 2016 Jun 28.
9
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice.在小鼠中,AKT和c-Met的共同激活通过mTORC1/FASN途径触发快速的肝细胞癌发展。
Sci Rep. 2016 Feb 9;6:20484. doi: 10.1038/srep20484.
10
Arginine Methylation of SREBP1a via PRMT5 Promotes De Novo Lipogenesis and Tumor Growth.SREBP1a 的精氨酸甲基化通过 PRMT5 促进从头脂肪生成和肿瘤生长。
Cancer Res. 2016 Mar 1;76(5):1260-72. doi: 10.1158/0008-5472.CAN-15-1766. Epub 2016 Jan 12.